EichorEICHOR
Location: Munich Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Munich

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Klinikum Rechts Der Isar Der Technischen Universität München · Eli Lilly and Company · NCT07218380
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386
Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles @Schule" (i Am Everything @school)
Phase N/A · LMU University Hospital (recruitment is conducted online) · Ludwig-Maximilians - University of Munich · NCT06668688
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · TUM Klinikum · Bristol-Myers Squibb · NCT07106762
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Frauen · Merck Sharp & Dohme LLC · NCT06393374
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Phase N/A · Institut für Diabetesforschung, Helmholtz Zentrum München · Helmholtz Zentrum München · NCT03316261
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · University Munich · Ad scientiam · NCT05566769
A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · Klinik und Poliklinik für Strahlentherapie und Radioonkologi · University of Erlangen-Nürnberg Medical School · NCT07131956
Register of Blood Stem Cell Transplantation
Phase N/A · Klinikum rechts der Isar der TU München · Technical University of Munich · NCT04263857
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
NA · European Radiosurgery Center Munich · University Hospital Schleswig-Holstein · NCT06914544
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic
Phase N/A · Department of Urology, LMU University Hospital, Ludwig-Maxim · Comprehensive Cancer Center Munich (CCCM) · NCT06657157
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Pfizer · NCT05895786
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Phase N/A · Technical University Munich · Erasmus Medical Center · NCT06273176
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · TUM Klinikum · Bristol-Myers Squibb · NCT06976216
Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
NA · University of Leipzig · NCT03469609
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · SAb Biotherapeutics, Inc. · NCT07187531
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Klinikum der Universität München Großhadern ( Site 0910) · Merck Sharp & Dohme LLC · NCT06833073
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D
Phase 2 · Site number - 6502 · Immunovant Sciences GmbH · NCT06979531
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · Praxiszentrum Dr. Med. Klaus Kruger Dres. Günther Kellerer U · AbbVie · NCT06712628
Infectious Complications After Cystectomy: A Prospective Observational Study
Phase N/A · Urology Department - LMU Klinikum · Ludwig-Maximilians - University of Munich · NCT05153694
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Phase 3 · LMU Klinikum der Universität München Neurologische Klinik un · Dyne Therapeutics · NCT07486934
HOPE Against Cancer Recurrence in HCC
Phase 4 · Philipp Dutkowski · NCT06717919
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719
Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy
NA · Okuvision GmbH · NCT07531927
TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium
NA · Department of Cardiovascular Surgery, German Heart Center Mu · Deutsches Herzzentrum Muenchen · NCT03600662
Pan Tumor Rollover Study
Phase 2 · Local Institution - 0276 · Bristol-Myers Squibb · NCT03899155
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
Phase 3 · University Hospital rechts der Isar, Radiation Oncology · University Hospital Heidelberg · NCT05331521
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · LMU Klinikum ( Site 0428) · Merck Sharp & Dohme LLC · NCT06890884
Look up another city
Look up another condition